Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alimta Plus Gemcitabine as Chemotherapy for Patients With Advanced Sarcoma: A Phase II Clinical

NCT00860015 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00860015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alimta Plus Gemcitabine as Chemotherapy for Patients With Advanced Sarcoma: A Phase II Clinical
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
April 30, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue